Reflecting recent business performance, Nippon Chemiphar Co., Ltd. has revised its forecasts issued on January 31, 2023.
Revised: Consolidated Forecasts for FY2022 (April 1, 2022-March31, 2023)
Net Income
attributable to
owners of
Net Sales
Operating
the parent
Earnings per
(¥mn)
Income (¥mn)
(¥mn)
Share (¥)
Previous forecast (A)
32,500
300
550
94.07
Revision (B)
31,559
(241)
339
152.50
Change (B - A)
(940)
(541)
(210)
% change
(2.9)
―
(38.3)
FY2021 results
32,506
825
700
194.33
The forecasts are based on currently available information, but the figures may change to reflect future conditions, thus causing results to differ.
For further information contact:
Public Relations Department, Nippon Chemiphar Co., Ltd. e-mail:ir@chemiphar.co.jp
Attachments
Original Link
Original Document
Permalink
Disclaimer
Nippon Chemiphar Co. Ltd. published this content on 08 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 May 2023 06:30:09 UTC.
NIPPON CHEMIPHAR CO., LTD. is a Japan-based company centered on ethical pharmaceutical products and mainly engaged in the pharmaceutical, health and beauty related businesses. The Companyâs Pharmaceutical segment is engaged in the manufacture and sale of ethical pharmaceutical products. Other businesses include entrusted safety testing, healthcare and real estate leasing business. The Company mainly operates in Japan and Vietnam.
NIPPON CHEMIPHAR CO., LTD. 